Persistent URL of this record https://hdl.handle.net/1887/3279610
Documents
-
- Download
- 1-s2.0-S0301472X20303088-main
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study
- All authors
- Hosnijeh, F.S.; Straten, L. van der; Kater, A.P.; Oers, M.H.J. van; Posthuma, W.F.M.; Chamuleau, M.E.D.; Bellido, M.; Doorduijn, J.K.; Gelder, M. van; Hoogendoorn, M.; Boer, F. de; Raa, G.D. te; Kerst, J.M.; Marijt, E.W.A.; Raymakers, R.A.P.; Koene, H.R.; Schaafsma, M.R.; Dobber, J.A.; Tonino, S.H.; Kersting, S.S.; Langerak, A.W.; Levin, M.D.
- Date
- 2020-09-01
- Journal
- Experimental Hematology
- Volume
- 89
- Pages
- 55 - 60